Identifying patient-level risk factors associated with non-beta-lactam resistance outcomes in invasive MRSA infections in the United States using chain graphs
JAC-ANTIMICROBIAL RESISTANCE, 4(4).
TL;DR:
The differences in resistance phenotypes between patients with previous healthcare use or positive blood cultures, or from different states, may be useful to inform first-choice antibiotics to treat clinical MRSA cases.
(via
Semantic Scholar)
UN Sustainable Development Goal Categories